|
|
|
|
|
|
Tech transfer complexity depends on product maturity, but don't assume a straightforward experience just because you have market approval and a commercial product. In fact, the risk is often greater. When outsourcing drug product manufacturing to scale up for clinical production or expanding capacity for a commercial product, it's best not to guess, Yan Zhi says in this segment of Cell & Gene Live "Viability On The Line." |
|
|
| What Is Transfection? | Article | Mirus Bio | Gain insight into the process of transfection and why it is crucial for studying gene function and has applications in various fields, including drug development and gene therapy. |
|
|
|
|
| CDMO Media And Buffer Outsourcing: A Strategic Advantage | Article | By Asma Ayari, Ph.D., Nucleus Biologics | Read how outsourcing cell culture media and buffers removes bottlenecks, freeing specialized CDMO resources. Ensure consistency, accelerate timelines, and streamline GMP readiness for client success. |
|
|
|
|
|
| Cytokines For Ex Vivo Cell Culture | Application Note | By Janet J. Sei, Rahul Purohit, Samatha Bandapalle, et al., Lonza | Comparable T cell expansion and function between cytokine sources were demonstrated. Generated CAR-T cells showed robust cytotoxicity and lower exhaustion markers. |
|
|
|
| Addressing The Challenges Of LNP Upscaling | Webinar | KNAUER | Overcome LNP upscaling challenges by leveraging fluid mechanical principles. See how Impingement Jets Mixing achieves reproducible turbulence and consistent LNP quality across all production scales. |
|
|
|
|
|
| Join Cell & Gene's Chief Editor, Erin Harris, for this timely Cell & Gene Live offering an in-depth regulatory outlook with two of the field's most trusted experts, Wilson Bryan, M.D., former director of FDA's Office of Tissues and Advanced Therapies (OTAT), and Daniela Drago, Ph.D., RAC, Partner at NDA Partners. Learn More! |
|
|
|
|
|
|
|
|
|
| Connect With Cell & Gene: |
|
|
|